Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Amino-terminal pro-brain natriuretic peptide in normal and hypertensive pregnancy.

Fleming SM, O'Byrne L, Grimes H, Daly KM, Morrison JJ.

Hypertens Pregnancy. 2001;20(2):169-75.

PMID:
12044327
2.

The comparison of amino-terminal probrain natriuretic peptide levels in preeclampsia and normotensive pregnancy.

Kale A, Kale E, Yalinkaya A, Akdeniz N, Canoruç N.

J Perinat Med. 2005;33(2):121-4.

PMID:
15843261
3.

Significance of plasma levels of N-terminal Pro-B-type natriuretic peptide on left ventricular remodeling in non-obstructive hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene.

Magga J, Sipola P, Vuolteenaho O, Risteli J, Jääskeläinen P, Peuhkurinen K, Kuusisto J.

Am J Cardiol. 2008 Apr 15;101(8):1185-90. doi: 10.1016/j.amjcard.2007.11.071. Epub 2008 Feb 20.

PMID:
18394456
4.

Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment.

Hunt PJ, Richards AM, Nicholls MG, Yandle TG, Doughty RN, Espiner EA.

Clin Endocrinol (Oxf). 1997 Sep;47(3):287-96.

PMID:
9373449
5.

NT-proANP and BNP in renovascular and in severe and mild essential hypertension.

Mussalo H, Vanninen E, Ikäheimo R, Hartikainen J.

Kidney Blood Press Res. 2003;26(1):34-41.

6.

Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction.

Nousiainen T, Vanninen E, Jantunen E, Puustinen J, Remes J, Rantala A, Vuolteenaho O, Hartikainen J.

J Intern Med. 2002 Mar;251(3):228-34.

7.

N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension.

Andreassen AK, Wergeland R, Simonsen S, Geiran O, Guevara C, Ueland T.

Am J Cardiol. 2006 Aug 15;98(4):525-9. Epub 2006 Jun 28.

PMID:
16893710
9.

High plasma N-terminal pro-brain natriuretic peptide level found in diabetic patients after myocardial infarction is associated with an increased risk of in-hospital mortality and cardiogenic shock.

Vergès B, Zeller M, Desgrès J, Dentan G, Laurent Y, Janin-Manificat L, L'Huillier I, Rioufol G, Beer JC, Makki H, Rochette L, Gambert P, Cottin Y.

Eur Heart J. 2005 Sep;26(17):1734-41. Epub 2005 Apr 14.

PMID:
15831555
10.
11.

Atrial and brain natriuretic peptide changes in an experimental model of intra-abdominal hypertension.

Argyra E, Theodoraki K, Rellia P, Marinis A, Voros D, Polymeneas G.

J Surg Res. 2013 Oct;184(2):937-43. doi: 10.1016/j.jss.2013.03.036. Epub 2013 Mar 31.

PMID:
23608621
12.

Brain natriuretic peptide is a good predictor for outcome in cardiac surgery.

Elíasdóttir SB, Klemenzson G, Torfason B, Valsson F.

Acta Anaesthesiol Scand. 2008 Feb;52(2):182-7. Epub 2007 Oct 19.

PMID:
17949462
13.

Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels.

Hong SN, Ahn Y, Yoon NS, Lee KH, Kim YS, Hwang SH, Lee SR, Kim KH, Park HW, Hong YJ, Kim JH, Jeong MH, Cho JG, Park JC, Kang JC.

Am J Cardiol. 2007 Apr 15;99(8):1051-4. Epub 2007 Mar 6.

PMID:
17437726
14.

N-terminal pro-B-type natriuretic peptide predicts total and cardiovascular mortality in individuals with or without stable coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health Study.

März W, Tiran B, Seelhorst U, Wellnitz B, Bauersachs J, Winkelmann BR, Boehm BO; LURIC Study Team.

Clin Chem. 2007 Jun;53(6):1075-83. Epub 2007 Apr 19.

15.

NT-pro-BNP in obstructive sleep apnea syndrome is decreased by nasal continuous positive airway pressure.

Tasci S, Manka R, Scholtyssek S, Lentini S, Troatz C, Stoffel-Wagner B, Lüderitz B.

Clin Res Cardiol. 2006 Jan;95(1):23-30.

PMID:
16598442
16.

Prognostic usefulness of anemia and N-terminal pro-brain natriuretic peptide in outpatients with systolic heart failure.

Schou M, Gustafsson F, Kistorp CN, Corell P, Kjaer A, Hildebrandt PR.

Am J Cardiol. 2007 Nov 15;100(10):1571-6.

PMID:
17996522
17.

Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.

Vanderheyden M, Bartunek, Claeys G, Manoharan G, Beckers JF, Ide L.

Clin Biochem. 2006 Jun;39(6):640-5. Epub 2006 Mar 3.

PMID:
16516185
18.

Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.

Potocki M, Mair J, Weber M, Hamm C, Burkard T, Hiemetzberger R, Peters K, Jander N, Cron TA, Hess N, Hoffmann A, Gekeler H, Gohlke-Bärwolf C, Buser P, Mueller C.

Am J Cardiol. 2009 Aug 15;104(4):559-64. doi: 10.1016/j.amjcard.2009.04.023. Epub 2009 Jun 18.

PMID:
19660612
19.
20.

Correlation between levels of N-terminal pro-B-type natriuretic peptide and degrees of heart failure.

Song BG, Jeon ES, Kim YH, Kang MK, Doh JH, Kim PH, Ahn SJ, Oh HL, Kim HJ, Sung JD, Lee SC, Gwon HC, Kim JS, Kim DK, Lee SH, Hong KP, Park JE, Lee SY, Lee JK.

Korean J Intern Med. 2005 Mar;20(1):26-32.

Supplemental Content

Support Center